Status:
UNKNOWN
Effect of Delta-9-Tetrahydrocannabinol on the Prevention of Chronic Pain in Patients With Acute CRPS (ETIC-Study)
Lead Sponsor:
Ludwig-Maximilians - University of Munich
Collaborating Sponsors:
German Federal Ministry of Education and Research
German Research Network on Neuropathic Pain
Conditions:
Complex Regional Pain Syndromes
CRPS
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine whether application of low dose Delta9-Tetrahydrocannabinol can prevent the development of chronic pain in patients with acute CRPS.
Detailed Description
Recent animal data suggest that the endocannabinoid system is a promising target in the prevention of chronic pain. It has been shown that the endocannabinoid system modifies excitatory and inhibitory...
Eligibility Criteria
Inclusion
- Patients with clinical diagnosis of acute CRPS (time from inciting event less than 16 weeks) of the upper extremity
- No risk of dependency in a psychological assessment
Exclusion
- History of alcohol or drug abuse
- Cardiac arrhythmias
- Acute or chronic renal failure
- ASA physical status classification III or higher
- Psychiatric disorders
- Pregnancy and breast feeding
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2008
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00377468
Start Date
September 1 2006
End Date
December 1 2008
Last Update
June 30 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology, Interdisciplinary Pain Clinic Grosshadern, Universitiy of Munich
Munich, Germany, 81377